Replimune Group, Inc.

REPL ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 May 20, 2026 OWNERSHIP DOCUMENT
4 May 20, 2026 OWNERSHIP DOCUMENT
4 May 20, 2026 OWNERSHIP DOCUMENT
SCHEDULE 13G/A May 15, 2026
SCHEDULE 13G May 12, 2026
SCHEDULE 13G/A May 7, 2026
8-K Apr 13, 2026 FORM 8-K
4 Apr 7, 2026 4
4 Apr 7, 2026 OWNERSHIP DOCUMENT
4 Apr 7, 2026 OWNERSHIP DOCUMENT
4 Apr 7, 2026 OWNERSHIP DOCUMENT
4 Apr 7, 2026 OWNERSHIP DOCUMENT
4 Apr 7, 2026 OWNERSHIP DOCUMENT
4 Apr 7, 2026 OWNERSHIP DOCUMENT
4 Apr 7, 2026 OWNERSHIP DOCUMENT
4 Apr 7, 2026 OWNERSHIP DOCUMENT
4 Apr 7, 2026 OWNERSHIP DOCUMENT
4 Apr 7, 2026 OWNERSHIP DOCUMENT
4 Apr 7, 2026 OWNERSHIP DOCUMENT
4 Apr 7, 2026 OWNERSHIP DOCUMENT
4 Apr 7, 2026 OWNERSHIP DOCUMENT
4 Apr 6, 2026 OWNERSHIP DOCUMENT
144 Apr 2, 2026
4 Feb 20, 2026 OWNERSHIP DOCUMENT
SCHEDULE 13G/A Feb 17, 2026
← Newer Page 3 of 27 · 662 filings Older →